Stoll, Christian: Phänotypische Untersuchungen zur prognostischen Bedeutung Proliferations- und Apoptose-assoziierter Faktoren sowie der Expression von Adhäsionsmolekülen in Plattenepithelkarzinomen der Mundhöhle und des Oropharynx

105

Literaturverzeichnis

1 . Adams JM, Cory S . "The Bcl-2 protein family: arbiters of cell survival" . Science 1998 ; 281 : 1322-6 .

2 . Ahomadegbe JC, Barrois M, Fogel S, LeBihan ML, Douc-Rasy S, Duvillard P, Armand JP, Riou G . "High incidence of p53 alterations (mutation, deletion, overexpression) in head and neck primary tumors and metastases; absence of correlation with clinical outcome. Frequent protein overexpression in normal epithelium and in early non-invasive lesions" . Oncogene 1995 ; 10 : 1217-27 .

3 . Ansari B, Coates PJ, Greenstein BD, Hall PA . "In situ end-labelling detects DNA strand breaks in apoptosis and other physiological and pathological states" . J Pathol 1993 ; 170 : 1-8 .

4 . Arnold A, Kim HG, Gaz RD, Eddy RL, Fukushima Y, Byers MG, Shows TB, Kronenberg HM . "Molecular cloning and chromosomal mapping of DNA rearranged with the parathyroid hormone gene in a parathyroid adenoma" . J Clin Invest 1989 ; 83 : 2034-40 .

5 . Baretton GB, Diebold J, Christoforis G, Vogt M, Müller C, Dopfer K, Schneiderbanger K, Schmidt M, Löhrs U . "Apoptosis and immunohistochemical bcl-2 expression in colorectal adenomas and carcinomas. Aspects of carcinogenesis and prognostic significance" . Cancer 1996 ; 77 : 255-64 .

6 . Baretton G, Xun L, Stoll C, Fischer-Brandies E, Schmidt M, Löhrs U . "Prognostic significance of DNA ploidy in oral squamous cell carcinomas. A retrospective flow and image cytometric study with comparison of DNA ploidy in excisional biopsy specimens and resection specimens, primary tumors, and lymph node metastases" . Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1995 ; 79 : 68-76 .

7 . Barak Y, Gottlieb E, Juven-Gershon T, Oren M . "Regulation of mdm2 expression by p53: alternative promotors produce transcripts with nonidentical translation potential" . Genes Dev 1994 ; 8 : 1739-49 .

8 . Barlogie B . "Abnormal cellular DNA content as a marker of neoplasia" . Eur J Cancer Clin Oncol 1984 ; 20 : 1123-5 .

9 . Barten M, Ostwald C, Müller P, Löning T, Milde-Langosch K, Wukasch Y . "P53 Alterationen und HPV Status in oralen Plattenepithelkarzinomen" . Verh Dtsch Ges Pathol 1994 ; 78 : 255-9 .

10 . Bartolazzi A, Nocks A, Aruffo A, Spring F, Stamenkovic I . "Glycosylation of CD44 is implicated in CD44-mediated cell adhesion to hyaluronan" . J Cell Biol 1996 ; 132 : 1199-208 .

11 . Battifora H . "P53 immunohistochemistry: A word of caution" . Hum Pathol 1994 ; 25 : 435-7 .

12 . Becker KF, Atkinson MJ, Reich U, Becker I, Nekarda H, Siewert JR, Höfler H . "E-cadherin gene mutations provide clues to diffuse type gastric carcinomas" . Cancer Res 1994 ; 54 : 3845-52 .

13 . Becker KF, Atkinson MJ, Reich U, Huang HH, Nekarda H, Siewert JR, Höfler H . "Exon skipping in the E-cadherin gene transscript in metastatic human gastric carcinoma" . Hum Mol Genet 1993 ; 2 : 803-4 .

14 . Becker KF, Höfler H . "Frequent somatic allelic inactivation of the E-cadherin gene in gastric carcinomas" . J Natl Cancer Inst 1995 ; 87 : 1082-4 .

15 . Becker N . Zeitlicher Trend der Fallzahlen und standardisierte Mortalitätsraten (ICD 140-149) . http://www.dkfz-heidelberg.de/epi/Homed/Programm/AG/Praevent/Krebshom/ main/ deutsch/frame5.htm , 1999 .

16 . Benedict WF, Xu HJ, Hu SX, Takahashi R . "Role of the retinoblastoma gene in the initiation and progression of human cancer" . J Clin Invest 1990 ; 85 : 988-93 .


106

17 . Bergsagel PL, Chesi M, Nardini E, Brents LA, Kirby SL, Kuehl WM . "Promiscuous translocations into immunoglobulin heavy chain switch regions in multiple myeloma" . Proc Natl Acad Sci U S A 1996 ; 93 : 13931-6 .

18 . Berx G, Cleton-Jansen AM, Nollet F, de Leeuw WJ, van de Vijver M, Cornelisse C, Van Roy F . "E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers" . EMBO J 1995 ; 14 : 6107-15 .

19 . Bier J . "Definition zum radikalchirurgischen Vorgehen bei Plattenepithelkarzinomen der Mundhöhle" . Dtsch Z Mund Kiefer Gesichtschir 1982 ; 6 : 369-72 .

20 . Bier J . "Tumoren im Mund-Kiefer-Gesichtsbereich" . In: Horch HH, Hrsg. Mund-Kiefer-Gesichtschirurgie II, Praxis der Zahnheilkunde 10/II , 2. Auflage. München : Urban & Schwarzenberg , 1991 , 267-359 .

21 . Birch M, Mitchell S, Hart IR . "Isolation and characterization of human melanoma cell variants expressing high and low levels of CD44" . Cancer Res 1991 ; 51 : 6660-7 .

22 . Birchall MA, Schock E, Harmon BV, Gobe G . "Apoptosis, mitosis, PCNA and bcl-2 in normal, leukoplakic and malignant epithelia of the human oral cavity: prospective, in vivo study" . Oral Oncol 1997 ; 33 : 419-25 .

23 . Birchmeier W, Hulsken J, Behrens J . "E-cadherin as an invasion suppressor" . Ciba Found Symp 1995 ; 189 : 124-36 .

24 . Blanquet V, Turleau C, Gross-Morand MS, Senamaud-Beaufort C, Doz F, Besmond C . "Spectrum of germline mutations in the RB1 gene: a study of 232 patients with hereditary and non hereditary retinoblastoma" . Hum Molec Genet 1995 ; 4 : 383-8 .

25 . Brehm A, Miska EA, McCance DJ, Reid JL, Bannister AJ, Kouzarides T . "Retinoblastoma protein recruits histone deacetylase to repress transcription" . Nature 1998 ; 391 : 597-601 .

26 . Brown TA, Bouchard T, St John T, Wayner E, Carter WG . "Human keratinocytes express a new CD44 core protein (CD44E) as a heparan-sulfate intrinsic membrane proteoglycan with additional exons" . J Cell Biol 1991 ; 113 : 207-21 .

27 . Buchkovich K, Duffy LA, Harlow E . "The retinoblastoma protein is phosphorylated during specific phases of the cell cycle" . Cell 1989 ; 58 : 1097-105 .

28 . Buhring HJ, Müller T, Herbst R, Cole S, Rappold I, Schüller W, Zhu X, Fritzsch U, Faul C, Armeanu S, Ullrich A, Klein G, Schmidt H . "The adhesion molecule E-cadherin and a surface antigen recognized by the antibody 9C4 are selectively expressed on erythroid cells of defined maturational stages" . Leukemia 1996 ; 10 : 106-16 .

29 . Bundesministerium für Gesundheit . Internationale Klassifikation der Krankheiten, Verletzungen und Todesursachen (ICD), 9. Revision , 2. Auflage. Köln : Kohlhammer , 1993 .

30 . Bunz F, Dutriaux A, Lengauer C, Waldman T, Zhou S, Brown JP, Sedivy JM, Kinzler KW, Vogelstein B . "Requirement for p53 and p21 to sustain G2 arrest after DNA damage" . Science 1998 ; 282 : 1497-501 .

31 . Burns JE, Baird MC, Clark LJ, Burns PA, Edington K, Chapman C, Mitchell R, Robertson G, Soutar D, Parkinson EK . "Gene mutations and increased levels of p53 protein in human squamous cell carcinomas and their cell lines" . Br J Cancer 1993 ; 67 : 1274-84 .

32 . Cairns J, Mao L, Merlo A, Lee DJ, Schwab D, Eby Y, Tokino K, van der Riet P, Blaugrund JE, Sidransky D . "Rates of p16 (MTS1) mutations in primary tumors with 9p loss" . Science 1994 ; 265 : 415-7 .

33 . Calzolari A, Chiarelli I, Bianchi S, Messerini L, Gallo O, Porfirio B, Mattiuz PL . "Immunohistochemical vs molecular biology methods. Complementary techniques for effective screening of p53 alterations in head and neck cancer" . Am J Clin Pathol 1997 ; 107 : 7-11 .


107

34 . Candidus S, Bischoff P, Becker KF, Höfler H . "No evidence for mutations in the alpha- and beta-catenin genes in human gastric and breast carcinomas" . Cancer Res 1996 ; 56 : 49-52 .

35 . Chandler D, El-Naggar AK, Brisbay S, Redline RW, McDonnell TJ . "Apoptosis and expression of the bcl-2 proto-oncogene in the fetal and adult human kidney: evidence for the contribution of bcl-2 expression to renal cancerogenesis" . Hum Pathol 1994 ; 25 : 789-96 .

36 . Chen PL, Scully P, Shew JY, Wang JY, Lee WH . "Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation" . Cell 1989 ; 58 : 1193-8 .

37 . Chesi M, Nardini E, Brents LA, Schrock E, Ried T, Kuehl WM, Bergsagel PL . "Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3" . Nature Genet 1997 ;16 : 260-4 .

38 . Cho Y, Gorina S, Jeffrey PD, Pavletich NP . "Crystal structure of a p53 tumor suppressor-DNA complex: understandig tumorigenic mutations" . Science 1994 ; 265 : 346-55 .

39 . Cianfriglia F, Di Gregorio DA, Manieri A . "Multiple primary tumours in patients with oral squamous cell carcinoma" . Oral Oncol 1999 ; 35 : 157-63 .

40 . Cleton-Jansen AM, Moerland EW, Kuipers-Dijkshoorn NJ, Callen DF, Sutherland GR, Hansen B, Devilee P, Cornelisse CJ . "At least two different regions are involved in allelic imbalance on chromosome arm 16q in breast cancer" . Genes Chromosom Cancer 1994 ; 9 : 101-7 .

41 . Combaret V, Lasset C, Frappaz D, Bouvier R, Thiesse P, Rebillard AC, Philip T, Favrot MC . "Evaluation of CD44 prognostic value in neuroblastoma: comparison with the other prognostic factors" . Eur J Cancer 1995 ; 31A : 545-9 .

42 . Connolly MJ, Payne RH, Johnson G, Gallie BL, Allderdice PW, Marshall WH, Lawton RD . "Familial, EsD-linked, retinoblastoma with reduced penetrance and variable expressivity" . Hum Genet 1983 ; 65 : 122-4 .

43 . Cordell JL, Falini B, Erber WN, Ghosh AK, Abdulaziz Z, MacDonald S, Pulford KA, Stein H, Mason DY . "Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes)" . J Histochem Cytochem 1984 ; 32 : 219-29 .

44 . Cordon-Cardo C . "Mutation of cell cycle regulators" . Am J Pathol 1995 ; 147 : 545-60 .

45 . Cox DR . "Regression models and life-tables (with discussion)" . J Roy Stat Soc 1972 ; 34 : 187-220 .

46 . Culty M, Nguyen HA, Underhill CB . "The hyaluronan receptor (CD44) participates in the uptake and degradation of hyaluronan" . J Cell Biol 1992 ; 116 : 1055-62 .

47 . Dall P, Heider KH, Sinn HP, Skroch-Angel P, Adolf G, Kaufmann M, Herrlich P, Ponta H . "Comparison of immunohistochemistry and RT-PCR for detection of CD44v-expression, a new prognostic factor in human breast cancer" . Int J Cancer 1995 ; 60 : 471-7 .

48 . Dazard JE, Augias D, Neel H, Mils V, Marechal V, Basset-Seguin N, Piette J . "MDM-2 protein is expressed in different layers of normal human skin" . Oncogene 1997 ; 14 : 1123-8 .

49 . DeCaprio JA, Ludlow JW, Figge J, Shew JY, Huang CM, Lee WH, Marsilio E, Paucha E, Livingston DM . "SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene" . Cell 1988 ; 54 : 275-83 .

50 . DeCaprio JA, Ludlow JW, Lynch D, Furukawa Y, Griffin J, Piwnica-Worms H, Huang CM, Livingston DM . "The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element" . Cell 1989 ; 58 : 1085-95 .


108

51 . DePinho RA . "The cancer-chromatin connection" . Nature 1998 ; 391 : 533-6 .

52 . Dianzani U, Malavasi F . "Lymphocyte adhesion to endothelium" . Crit Rev Immunol 1995 ; 15 : 167-200 .

53 . Doglioni C, Dei-Tos AP, Laurino L, Chiarelli C, Barbareschi M, Viale G . "The prevalence of Bcl-2-immunoreactivity in breast carcinomas and its clinicopathological correlates, with particular reference to oestrogen receptor status" . Virchows Arch 1994 ; 424 : 47-51 .

54 . Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery CA, Butel JS, Bradley A . "Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours" . Nature 1992 ; 356 : 215-21 .

55 . Dorudi S, Hart IR . "Mechanisms underlying invasion and metastasis" . Curr Opin Oncol 1993 ; 5 : 130-5 .

56 . Drenning SD, Marcovitch AJ, Johnson DE, Melhem MF, Tweardy DJ, Grandis JR . "Bcl-2 but not Bax expression is associated with apoptosis in normal and transformed squamous epithelium" . Clin Cancer Res 1998 ; 4 : 2913-21 .

57 . Dyson H, Howley PM, Munger K, Harlow E . "The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product" . Science 1989 ; 243 : 934-7 .

58 . Eisterer W, Hilbe W, Stauder R, Bechter O, Fend F, Thaler J . "An aggressive subtype of B-CLL is characterized by strong CD44 expression and lack of CD11c" . Br J Haematol 1996 ; 93 : 661-9 .

59 . EI-Deiry WS, Tokino T, VeIkulescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer E, Kinzler KW, Vogelstein B . "WAF1, a potential mediator of p53 tumor suppression" . Cell 1993 ; 75 : 817-25 .

60 . El-Deiry WS, Tokino T, Waldman T, Oliner JD, Velculescu VE, Burrell M, Hill DE, Healy E, Rees JL, Hamilton SR, Kinzler KW, Vogelstein B . "Topological control of p21/WAF1/CIP1 expression in normal and neoplastic tissues" . Cancer Res 1995 ; 55 : 2910-9 .

61 . Eng C, Ponder BA . "The role of gene mutations in the genesis of familial cancer" . FASEB J 1993 ; 7 : 910-9 .

62 . Evan G, Littlewood T . "A matter of life and cell death" . Science 1998 ; 281 : 1317-22 .

63 . Fakharzadeh SS, Trusko SP, George DL . "Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumor cell line" . EMBO J 1991 ; 10 : 1565-9 .

64 . Field JK, Pavelic ZP, Spandidos DA, Stambrook PJ, Jones AS, Gluckman JL . "The role of the p53 tumor suppressor gene in squamous cell carcinoma of the head and neck" . Arch Otolaryngol Head Neck Surg 1993 ; 119 : 1118-22 .

65 . Field JK, Spandidos DA, Malliri A, Gosney JR, Yiagnisis M, Stell PM . "Elevated p53 expression correlates with a history of heavy smoking in squamous cell carcinoma of the head and neck" . Br J Cancer 1991 ; 64 : 573-7 .

66 . Freeman RS, Donoghue DJ . "Protein kinases and protooncogenes: biochemical regulators of the eukaryotic cell cycle" . Biochemistry 1991 ; 30 : 2293-302 .

67 . Friedrichs K, Franke F, Lisboa BW, Kugler G, Gille I, Terpe HJ, Hölzel F, Maass H, Günthert U . "CD44 isoforms correlate with cellular differentiation but not with prognosis in human breast cancer" . Cancer Res 1995 ; 55 : 5424-33 .

68 . Friend SH, Horowitz JM, Gerber MR, Wang XF, Bogenmann E, Li FP, Weinberg RA . "Deletions of a DNA sequence in retinoblastomas and mesenchymal tumors: organization of the sequence and its encoded protein" . Proc Natl Acad Sci U S A 1987 ; 84 : 9059-63 .


109

69 . Frixen UH, Nagamine Y . "Stimulation of urokinase-type plasminogen activator expression by blockage of E-cadherin-dependent cell-cell adhesion" . Cancer Res 1993 ; 53 : 3618-23 .

70 . Fröhlich M . "Epidemiologie der Lippen- und Mundschleimhautkarzinome" . Med aktuell 1991 ; 17 : 180-1 .

71 . Gapany M, Pavelic ZP, Gapany SR, Pavelic L, Li Y, Craven JM, Jones H, Biddinger P, Stambrook PJ, Gluckman JL . "Relationship between immunohistochemically detectable p53 protein and prognostic factors in head and neck tumors" . Cancer Detect Prev 1993 ; 17 : 379-86 .

72 . Gavrieli Y, Sherman Y, Ben-Sasson SA . "Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation" . J Cell Biol 1992 ; 119 : 493-501 .

73 . Gehan EH . "A generalized Wilcoxon test for comparing arbitrarily singly-censored samples" . Biometrika 1965 ; 52 : 203-23 .

74 . Gerdes J, Schwab U, Lemke H, Stein H . "Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation" . Int J Cancer 1983 ; 31 : 13-20 .

75 . Givehchian M, Woerner SM, Lacroix J, Zöller M, Drings P, Becker H, Kayser K, Ridder R, von Knebel-Doeberitz M . "Expression of CD44 splice variants in normal respiratory epithelium and bronchial carcinomas: no evidence for altered CD44 splicing in metastasis" . Oncogene 1996 ; 12 : 1137-44 .

76 . Goodman LA, Kruskal WH . "Measures of association for cross-classifications" . J Am Statist Assoc 1954 ; 49 : 732-64 .

77 . Gorgoulis VG, Rassidakis GZ, Karameris AM, Papastamatiou H, Trigidou R, Veslemes M, Rassidakis AN, Kittas C . "Immunohistochemical and molecular evaluation of the mdm-2 gene product in brochogenic carcinoma" . Mod Pathol 1996 ; 9 : 544-54 .

78 . Graff JR, Herman JG, Lapidus RG, Chopra H, Xu R, Jarrard DF, Isaacs WB, Pitha PM, Davidson NE, Baylin SB . "E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas" . Cancer Res 1995 ; 55 : 5195-9 .

79 . Grand RJ, Lecane PS, Owen D, Grant ML, Roberts S, Levine AJ, Gallimore PH . "The high levels of p53 present in adenovirus early region 1-transformed human cells do not cause up-regulation of MDM2 expression" . Virology 1995 ; 210 : 323-34 .

80 . Green DR . "Apoptotic pathways: the roads to ruin" . Cell 1998 ; 94 : 695-8 .

81 . Green DR, Reed JC . "Mitochondria and apoptosis" . Science 1998 ; 281 : 1309-12 .

82 . Greenblatt MS, Benett WP, Hollstein M, Harris CC . "Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis" . Cancer Res 1994 ; 54 : 4855-78 .

83 . Grimm G . "Geschwülste im Mund- und Kieferbereich" . In: Schwenzer N, Grimm G, Hrsg. Zahn-Mund-Kiefer-Heilkunde, Spezielle Chirurgie , Band 2 , 2. Auflage. Stuttgart : Thieme , 1990 , 253-357 .

84 . Günthert U . "CD44: a multitude of isoforms with diverse functions" . Curr Top Microbiol Immunol 1993 ; 184 : 47-63 .

85 . Günthert U, Hofmann M, Rudy W, Reber S, Zöller M, Haussmann I, Matzkus S, Wenzel A, Ponta H, Herrlich P . "A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells" . Cell 1991 ; 65 : 13-24 .

86 . Gumbiner BM . "Cell adhesion: the molecular basis of tissue architecture and morphogenesis" . Cell 1996 ; 84 : 345-57 .

87 . Hall PA, Lane DP . "P53 in tumour pathology: can we trust immunohistochemistry? - revisited" . J Pathol 1994 ; 172 : 1-4 .


110

88 . Harbour JW, Luo RX, Dei Santi A, Postigo AA, Dean DC . "Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1" . Cell 1999 ; 98 : 859-69 .

89 . Hardingham TE, Fosang AJ . "Proteoglycans: many forms and many functions" . FASEB J 1992 ; 6 : 861-70 .

90 . Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ . "The p21 cdk-interacting protein cip1 is a potent inhibitor of G1 cyclin-dependent kinases" . Cell 1993 ; 75 : 805-16 .

91 . Harris CC, Hollstein M . "Clinical implications of the p53 tumor-suppressor gene" . New Engl J Med 1993 ; 329 : 1318-27 .

92 . Hartwell LH, Kastan MB . "Cell cycle control and cancer" . Science 1994 ; 266 : 1821-8 .

93 . Hashimoto M, Niwa O, Nitta Y, Takeichi M, Yokoro K . "Unstable expression of E-Cadherin adhesion molecules in metastatic ovarian tumor cells" . Jpn J Cancer Res 1989 ; 80 : 459-63 .

94 . Hatta K, Nose A, Nagafuchi A, Takeichi M . "Cloning and expression of cDNA encoding a neural calcium-dependent call adhesion molecule: its identity in the cadherin gene family" . J Cell Biol 1988 ; 106 : 873-81 .

95 . Hazan RB, Norton L . "The epidermal growth factor receptor modulates the interaction of E-cadherin with the actin cytoskeleton" . J Biol Chem 1998 ; 273 : 9078-84 .

96 . Herold-Mende C, Seiter S, Born Al, Patzelt E, Schupp M, Zöller J, Bosch FX, Zöller M . "Expression of CD44 splice variants in squamous epithelia and squamous cell carcinomas of the head and neck" . J Pathol 1996 ; 179 : 66-73 .

97 . Hockenberry D, Nunez G, Milliman C, Schreiber RD, Korsmeyer SJ . "Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death" . Nature 1990 ; 348 : 334-6 .

98 . Hockenbery DM, Zutter M, Hickey W, Nahm M, Korsmeyer SJ . "Bcl2 protein is topographically restricted in tissues characterized by apoptotic cell death" . Proc Natl Acad Sci U S A 1991 ; 88 : 6961-5 .

99 . Hofmann M, Rudy W, Zöller M, Tolg C, Ponta H, Herrlich P, Günthert U . "CD44 splice variants confer metastatic behavior in rats: homologous sequences are expressed in human tumor cell lines" . Cancer Res 1991 ; 51 : 5292-7 .

100 . Hollstein M, Sidransky D, Vogelstein B, Harris CC . "P53 mutations in human cancers" . Science 1991 ; 253 : 49-53 .

101 . Hong FD, Huang HJ, To H, Young LJ, Oro A, Bookstein R, Lee EY, Lee WH . "Structure of the human retinoblastoma gene" . Proc Natl Acad Sci U S A 1989 ; 86 : 5502-6 .

102 . Honn KV, Tang DG . "Adhesion molecules and tumor cell interaction with endothelium and subendothelial matrix" . Cancer Metast Rev 1992 ; 11 : 353-75 .

103 . Horowitz JM, Park SH, Yandell DW, Weinberg RA . "Involvement of the retinoblastoma gene in the genesis of various human tumors" . In: Kavenee W, Hastie N, Stanbridge E, eds. Recessive oncogenes und tumor suppression: current communications in molecular biology . Cold Spring Habor, New York : Cold Spring Habor Laboratory Press , 1989 , 101-8 .

104 . Howes KA, Ransom N, Papermaster DS, Lasudry JG, Albert DM, Windle JJ . "Apoptosis or retinoblastoma: alternative fates of photoreceptors expressing the HPV-16 E7 gene in the presence or absence of p53" . Genes Dev 1994 ; 8 : 1300-10 .

105 . Hsu YT, Wolter KG, Youle RJ . "Cytosol-to-membrane redistribution of Bax and Bcl-XL during apoptosis" . Proc Natl Acad Sci U S A 1997 ; 94 : 3668-72 .

106 . Hsu YT, Youle RJ . "Bax in murine thymus is a soluble monomeric protein that displays differential detergent-induced conformations" . J Biol Chem 1998 ; 273 : 10777-83 .


111

107 . Huang LC, Clarkin KC, Wahl GM . "Sensitivity and selectivity of the DNA damage sensor responsible for activating p53-dependent G1 arrest" . Proc Natl Acad Sci U S A 1996 ; 93 : 4827-32 .

108 . Hudson DL, Sleeman J, Watt FM . "CD44 is the major peanut lectin-binding glycoprotein of human epidermal keratinocytes and plays a role in intercellular adhesion" . J Cell Sci 1995 ; 108 : 1959-70 .

109 . Hudson DL, Speight PM, Watt FM . "Altered expression of CD44 isoforms in squamous cell carcinomas and cell lines derived from them" . Int J Cancer 1996 ; 66 : 457-63 .

110 . Hulsken J, Birchmeier W, Behrens J . "E-Cadherin and APC compete for the interaction with beta-catenin and cytoskeleton" . J Cell Biol 1994 ; 125 : 2061-9 .

111 . Ihara T, Yamamoto T, Sugamata M, Okumura H, Ueno Y . "The process of ultrastructural changes from nuclei to apoptotic body" . Virchows Arch 1998 ; 433 : 443-7 .

112 . Imhof BA, Vollmers HP, Goodman SL, Birchmeier W . "Cell-cell interaction and polarity of epithelial cells: specific pertubation using a monoclonal antibody" . Cell 1983 ; 35 : 667-75 .

113 . Isacke CM . "The role of cytoplasmic domain in regulating CD44 function" . J Cell Science 1994 ; 107 : 2353-9 .

114 . Jalkanen S, Jalkanen M . "Lymphocyte CD44 binds the COOH-terminal heparin-binding domain of fibronectin" . J Cell Biol 1992 ; 116 : 817-25 .

115 . Jansen LA, Mesnil M, Jongen WM . "Inhibition of gap junctional intercellular communication and delocalization of the cell adhesion molecule E-cadherin by tumor promoters" . Carcinogenesis 1996 ; 17 : 1527-31 .

116 . Jeffrey PD, Gorina S, Pavletich NP . "Crystal structure of the tetramerization domain of the p53 tumor suppressor at 1.7 angstroms" . Science 1995 ; 267 : 1498-502 .

117 . Jensen PJ, Wheelock MJ . "Regulation of urokinase plasminogen activator localization in keratinocytes by calcium ion and E-cadherin" . Exp Cell Res 1992 ; 202 : 190-8 .

118 . Jiang WG . "E-cadherin and its associated protein catenins, cancer invasion and metastasis" . Br J Surg 1996 ; 83 : 437-46 .

119 . Jordan RC, Catzavelos GC, Barrett AW, Speight PM . "Differential expression of bcl-2 and bax in squamous cell carcinomas of the oral cavity" . Oral Oncol, Eur J Cancer 1996 ; 32B : 394-400 .

120 . Kadowaki T, Shiozaki H, Inoue M, Tamura S, Oka H, Doki Y, Iihara K, Matsui S, Iwazawa T, Nagafuchi A . "E-cadherin and alpha-catenin expression in human esophageal cancer" . Cancer Res 1994 ; 54 : 291-6 .

121 . Kainz C, Tempfer C, Kohlberger P, Janisch S, Koelbl H, Gitsch G, Breitenecker G . "lmmunohistochemical detection of adhesion molecule CD44 splice variants in lymph node metastases of cervical cancer" . Int J Cancer 1996 ; 69 : 170-3 .

122 . Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, Stockert E, Day RS, Johnson BE, Skolnick MH . "A cell cycle regulator potentially involved in genesis of many tumor types" . Science 1994 ; 264 : 436-40 .

123 . Kanai Y, Oda T, Tsuda H, Ochiai A, Hirohashi S . "Point mutation of the E-cadherin gene in invasive lobular carcinoma of the breast" . Jpn J Cancer Res 1994 ; 85 : 1035-9 .

124 . Kaplan EL, Meier P . "Nonparametric estimation from incomplete observations" . J Am Statist Assoc 1958 ; 53 : 457-81 .

125 . Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW . "Participation of p53 protein in the cellular response to DNA damage" . Cancer Res 1991 ; 51 : 6304-11 .

126 . Katayama M, Hirai S, Kamihagi K, Nakagawa K, Yasumoto M, Kato I . "Soluble E-cadherin fragments increased in circulation of cancer patients" . Br J Cancer 1994 ; 69 : 580-5 .


112

127 . Katayama M, Hirai S, Yasumoto M, Kato I . "Soluble fragments of E-cadherin cell adhesion molecule increase in urinary excretion of cancer patients, potentially indicating its shedding from epithelial tumor cells" . Int J Oncol 1994 ; 5 : 1049-57 .

128 . Kaufmann M, Heider KH, Sinn HP, von Minckwitz G, Ponta H, Herrlich P . "CD44 variant exon epitopes in primary breast cancer and length of survival" . Lancet 1995 ; 345 : 615-9 .

129 . Kelekar A, Thompson CB . "Bcl-family proteins: the role of the BH3 domain in apoptosis" . Trends Cell Biol 1998 ; 8 : 324-30 .

130 . Kerr JF, Winterford CM, Harmon BV . "Apoptosis. Its significance in cancer and cancer therapy" . Cancer 1994 ; 73 : 2013-26 .

131 . Kerr JF, Wyllie AH, Currie AR . "Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics" . Br J Cancer 1972 ; 26 : 239-57 .

132 . Knudson AG . "Mutation and cancer: statistical study of retinoblastoma" . Proc Natl Acad Sci U S A 1971 ; 68 : 820-3 .

133 . Ko LJ, Prives C . "P53: puzzle and paradigm" . Genes Dev 1996 ; 10 : 1054-72 .

134 . Koh JY, Cho NP, Kong G, Lee JD, Yoon K . "P53 mutations and human papillomavirus DNA in oral squamous cell carcinoma: correlation with apoptosis" . Br J Cancer 1998 ; 78 : 354-9 .

135 . Korabiowska M, Brinck U, Honig J, Mora O, Bartkowski S, Schauer A . "CD44: a marker of metastases of head and neck melanomas" . In Vivo 1995 ; 9 : 253-6 .

136 . Korsmeyer SJ . "Bcl-2 initiates a new category of oncogenes: regulators of cell death" . Blood 1992 ; 80 : 879-86 .

137 . Kovesdi I, Reichel R, Nevins JR . "Identification of a cellular transcription factor involved in E1A trans-activation" . Cell 1986 ; 45 : 219-28 .

138 . Krüger E . Lehrbuch der chirurgischen Zahn-, Mund- und Kieferheilkunde , Band 2 , 7. Auflage. Berlin : Quintessenz , 1993 , 379-598 .

139 . Kruskal WH, Wallis WA . "Use of ranks in one-criterion variance analysis" . J Am Statist Assoc 1952 ; 47 : 583-621 .

140 . Kugelman LC, Ganguly S, Haggerty JG, Weissman SM, Milstone LM . "The core protein of epican, a heparan sulfate proteoglycan on keratinocytes, is an alternative form of CD44" . J Invest Dermatol 1992 ; 99 : 381-5 .

141 . Kunishi M, Kayada Y, Yoshiga K . "Down-regulated expression of CD44 variant 6 in oral squamous cell carcinomas and its relationship to regional lymph node metastasis" . Int J Oral Maxillofac Surg 1997 ; 26 : 280-3 .

142 . Kuwashima Y, Uehara T, Kishi K, Shiromizu K, Matsuzawa M, Takayama S . "Immunohistochemical characterization of undifferentiated carcinomas of the ovary" . J Cancer Res Clin Oncol 1994 ; 120 : 672-7 .

143 . Lane DP . "P53, guardian of the genome" . Nature 1992 ; 358 : 15-6 .

144 . Lane DP, Crawford LV . "T antigen is bound to a host protein in SV40-transformed cells" . Nature 1979 ; 278 : 261-3 .

145 . Langdon JD, Partridge M . "Expression of the tumour suppressor gene p53 in oral cancer" . Br J Oral Maxillofac Surg 1992 ; 30 : 214-20 .

146 . Laurent TC, Fraser JR . "Hyaluronon" . FASEB J 1992 ; 6 : 2397-404 .

147 . Lauwers GY, Scott GV, Karpeh MS . "Immunohistochemical evaluation of bcl-2 protein expression in gastric adenocarcinomas" . Cancer 1995 ; 75 : 2209-13 .

148 . Lavieille JP, Brambilla E, Riva-Lavieille C, Reyt E, Charachon R, Brambilla C . "Immunohistochemical detection of p53 protein in preneoplastic lesions and squamous cell carcinoma of the head and neck" . Acta Otolaryngol Stockh 1995 ; 115 : 334-9 .


113

149 . Lee WH, Bookstein R, Hong F, Young LJ, Shew JY, Lee EY . "Human retinoblastoma susceptibility gene: cloning, identification, and sequence" . Science 1987 ; 235 : 1394-9 .

150 . Lesley J, English N, Perschl A, Gregoroff J, Hyman R . "Variant cell lines selected for alterations in the function of the hyaluronan receptor CD44 show differences in glycosylation" . J Exp Med 1995 ; 182 : 431-7 .

151 . Lesley J, He Q, Miyake K, Hamann A, Hyman R, Kincade PW . "Requirements for hyaluronic acid binding by CD44: a role for the cytoplasmic domain and activation by antibody" . J Exp Med 1992 ; 175 : 257-66 .

152 . Lesley J, Howes N, Perschl A, Hyman R . "Hyaluronan binding function of CD44 is transiently activated on T cells during an in vivo immune response" . J Exp Med 1994 ; 180 : 383-7 .

153 . Lesley J, Hyman R, Kincade PW . "CD44 and its interaction with extracellular matrix" . Adv Immunol 1993 ; 54 : 271-335 .

154 . Levine AJ, Momand J, Finlay CA . "The p53 tumour suppressor gene" . Nature 1991 ; 351 : 453-6 .

155 . Li FP, Fraumeni JF . "Rhabdomyosarcoma in children: epidemiologic study and identification of a familiar cancer syndrome" . J Natl Cancer Inst 1969 ; 43 : 1365-73 .

156 . Linden MD, Torres FX, Kubus J, Zarbo RJ . "Clinical application of morphologic and immunocytochemical assessments of cell proliferation" . Am J Clin Pathol (Suppl) 1992 ; 97 : 4-13 .

157 . Little M, Wainwright B . "Methylation and p16: suppressing the suppressor" . Nature Med 1995 ; 1 : 633-4 .

158 . Lohmann DR, Gerick M, Brandt B, Oelschlager U, Lorenz B, Passarge E, Horsthemke B . "Constitutional RB1-gene mutations in patients with isolated unilateral retinoblastoma" . Am J Hum Genet 1997 ; 61 : 282-94 .

159 . Luo RX, Postigo AA, Dean DC . "Rb interacts with histone deacetylase to repress transcription" . Cell 1998 ; 92 : 463-73 .

160 . Mackay CR, Terpe HJ, Stauder R, Marston WL, Stark H, Günthert U . "Expression and modulation of CD44 variant isoforms in humans" . J Cell Biol 1994 ; 124 : 71-82 .

161 . Magnaghi-Jaulin L, Groisman R, Naguibneva I, Robin P, Lorain S, Le-Villain JP, Troalen F, Trouche D, Harel-Bellan A . "Retinoblastoma protein represses transcription by recruiting a histone deacetylase" . Nature 1998 ; 391 : 601-5 .

162 . Malkin D, Li FP, Strong LC, Fraumeni JF, Nelson CE, Kim DH, Kassel J, Gryka MA, Bischoff FZ, Tainsky MA, Friend SH . "Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms" . Science 1990 ; 250 : 1233-8 .

163 . Mann HB, Whitney DR . "On a test of whether one of two random variables is stochastically larger than the other" . Ann Math Statist 1947 ; 18 : 50-60 .

164 . Mantel N . "Ranking procedures for arbitrarily restricted observations" . Biometrics 1967 ; 23 : 65-78 .

165 . Mareel M, Behrens J, Birchmeier W, De Bruyne GK, Vlemminckx K, Hoogewijw A . "Down-regulation of E-cadherin in Madin-Darby canine kidney (MDCK) cells inside tumors of nude mice" . Int J Cancer 1991 ; 47 : 922-8 .

166 . Mareel M, Bracke M, van Roy F . "Cancer metastasis: negative regulation by an invasion-suppressor complex" . Cancer Detect Prev 1995 ; 19 : 451-64 .

167 . Matsui S, Shiozaki H, Inoue M, Tamura S, Doki Y, Kadowaki T, Iwazawa T, Shimaya K, Nagafuchi A, Tsukita S "Immunohistochemical evaluation of alpha-catenin expression in human gastric cancer" . Virchows Arch 1994 ; 424 : 375-81 .


114

168 . Matsumura T, Yoshihama Y, Kimura T, Shintani S, Alcalde RE . "P53 and MDM2 expression in oral squamous cell carcinoma" . Oncology 1996 ; 53 : 308-12 .

169 . Matsuta M, Kon S, Sasaki K, Matsuta M . "Immunohistochemical detection of p21WAF1/CIP1 and p53 proteins in formalin-fixed paraffin-embedded tissue sections of squamous cell carcinoma of the skin" . J Dermatol Sci 1997 ; 14 : 233-9 .

170 . Mayer B, Jauch KW, Günthert U, Figdor CG, Schildberg FW, Funke I, Johnson JP . "De-novo expression of CD44 and survival in gastric cancer" . Lancet 1993 ; 342 : 1019-22 .

171 . McDonnell TJ, Nunez G, Platt FM, Hockenberry D, London L, McKearn JP, Korsmeyer SJ . "Deregulated Bcl-2-immunoglobulin transgene expands a resting but responsive immunoglobulin M and D-expressing B-cell population" . Mol Cell Biol 1990 ; 10 : 1901-7 .

172 . Merkel DE, McGuire WL . "Ploidy, proliferative activity and prognosis. DNA flow cytometry of solid tumors" . Cancer 1990 ; 65 : 1194-205 .

173 . Merlo A, Herman JG, Mao L, Lee DJ, Gabrielson E, Burger PC, Baylin SB, Sidransky D . "5-prime CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers" . Nature Med 1995 ; 1 : 686-92 .

174 . Metelmann HR . "Tumoren im Kopf-Halsbereich" . In: Horch HH, Hrsg. Mund-Kiefer-Gesichtschirurgie II, Praxis der Zahnheilkunde 10/II , 3. Auflage. München : Urban & Schwarzenberg , 1998 , 249-328 .

175 . Michieli P, Chedid M, Lin D, Pierce JH, Mercer WE, Givol D . "Induction of WAF1/CIP1 by a p53-independent pathway" . Cancer Res 1994 ; 54 : 3391-5 .

176 . Milstone LM, Hough-Monroe L, Kugelman LC, Bender JR, Haggerty JG . "Epican, a heparan/chondroitin sulfate proteoglycan form of CD44, mediates cell-cell adhesion" . J Cell Sci 1994 ; 107 : 3183-90 .

177 . Min BM, Baek JH, Shin KH, Gujuluva CN, Cherrick HM, Park NH . "Inactivation of the p53 gene by either mutation or HPV infection is extremely frequent in human oral squamous cell carcinoma cell lines" . Eur J Cancer B Oral Oncol 1994 ; 30 : 338-45 .

178 . Mitchell EL, White GR, Santibanez-Koref MF, Varley JM, Heighway J . "Mapping of gene loci in the q13-q15 region of chromosome 12" . Chromosome Res 1995 ; 3 : 261-2 .

179 . Mittermayer C . Oralpathologie , 3. Auflage. Stuttgart : Schattauer , 1993 , 80-110 .

180 . Miyashita T, Reed JC . "Tumor suppressor p53 is a direct transcriptional activator of the human bax gene" . Cell 1995 ; 80 : 293-9 .

181 . Momand J, Zambetti GP, Olson DC, George D, Levine AJ . "The mdm2-oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation" . Cell 1992 ; 69 : 1237-45 .

182 . Morgenbesser SD, Willians BO, Jacks T, DePinho RA . "P53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens" . Nature 1994 ; 371 : 72-4 .

183 . Munro SB, Turner IM, Farookhi R, Blaschuk OW, Jothy S . "E-cadherin and OB-cadherin mRNA levels in normal human colon and colon carcinoma" . Exp Mol Pathol 1995 ; 62 : 118-22 .

184 . Nagafuchi A, Takeichi M, Tsukita S . "The 102 kD cadherin-associated protein: similarity to vinculin and post-transcriptional regulation of expression" . Cell 1991 ; 65 : 849-57 .

185 . Nagar B, Overduin M, Ikura M, Rini JM . "Structural basis of calcium-induced E-cadherin rigidification and dimerization" . Nature 1996 ; 380 : 360-4 .

186 . Naor D, Sionov RV, Ish-Shalom D . "CD44: Structure, function, and association with the malignant process" . Adv Cancer Res 1997 ; 71 : 241-319 .

187 . Neame SJ, Isacke CM . "Phosphorylation of CD44 in vivo requires both Ser 323 and Ser 325, but does not regulate membrane localization or cytoskeletal interaction in epithelial cells" . EMBO J 1992 ; 11 : 4733-8 .


115

188 . Nees M, Homann N, Discher H, Andl T, Enders C, Herold-Mende C, Schuhmann A, Bosch FX . "Expression of mutated p53 occurs in tumor-distant epithelia of head and neck cancer patients: a possible molecular basis for the development of multiple tumors" . Cancer Res 1993 ; 53 : 4189-96 .

189 . Neumann HG . "Entstehung und Behandlung von Tumoren" . In: Forth W, Henschler D, Rummel W, Starke K, Hrsg. Pharmakologie und Toxikologie , 6. Auflage. Mannheim : Wissenschaftsverlag , 1992 , 722-46 .

190 . Newton K, Strasser A . "The Bcl-2 family and cell death regulation" . Curr Opin Genet Dev 1998 ; 8 : 68-75 .

191 . Nishioka H, Hiasa Y, Hayashi I, Kitahori Y, Konishi N, Sugimura M . "Immunohistochemical detection of p53 oncoprotein in human oral squamous cell carcinomas and leukoplakias: comparison with proliferating cell nuclear antigen staining and correlation with clinicopathological findings" . Oncology 1993 ; 50 : 426-9 .

192 . Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K, Carson DA . "Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers" . Nature 1994 ; 368 : 753-6 .

193 . Noda A, Ning Y, Venable SF, Pereira-Smith OM, Smith JR . "Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen" . Exp Cell Res 1994 ; 211 : 90-8 .

194 . Nowell PC . "The clonal evolution of tumor cell populations" . Science 1976 ; 194 : 23-8 .

195 . Nurse P . "Ordering S phase and M phase in the cell cycle" . Cell 1994 ; 79 : 547-50 .

196 . Nylander K, Nilsson P, Mehle C, Roos G . "P53 mutations, protein expression and cell proliferation in squamous cell carcinomas of the head and neck" . Br J Cancer 1995 ; 71 : 826-30 .

197 . Nylander K, Schildt EB, Eriksson M, Roos G . "PCNA, Ki-67, p53, bcl-2 and prognosis in intraoral squamous cell carcinoma of the head and neck" . Anal Cell Pathol 1998 ; 14 : 101-10 .

198 . Oliner JD, Kinzler KW, Metzler PS, George DL, Vogelstein B . "Amplification of a gene encoding a p53-associated protein in human sarcomas" . Nature 1992 ; 358 : 80-3 .

199 . Oliveira DT, Odell EW . "Expression of CD44 variant exons by normal oral epithelia" . Oral Oncol 1997 ; 33 : 260-2 .

200 . Oltvai ZN, Milliman CL, Korsmeyer SJ . "Bcl-2 heterodimerizes in vivo with a conserved homolog, bax, that accelerates programmed cell death" . Cell 1993 ; 74 : 609-19 .

201 . Oren M . "The involvement of oncogenes and tumor suppressor genes in the control of apoptosis" . Cancer Metastasis Rev 1992 ; 11 : 141-8 .

202 . Patel DD, Hale LP, Whichard LP, Radcliff G, Mackay CR, Haynes BF . "Expression of CD44 molecules and CD44 ligands during human thymic fetal development: expression of CD44 isoforms is developmentally regulated" . Int Immunol 1995 ; 7 : 277-86 .

203 . Pavletich NP, Chambers KA, Pabo CO . "The DNA-binding domain of p53 contains the four conserved regions and the major mutation hotspots" . Genes Dev 1993 ; 7 : 2556-64 .

204 . Peach RJ, Hollenbaugh D, Stamenkovic I, Aruffo A . "Identification of hyaluronic acid binding sites in the extracellular domain of CD44" . J Cell Biol 1993 ; 122 : 257-64 .

205 . Pena JC, Thompson CB, Recant W, Vokes EE, Rudin CM . "Bcl-xL and Bcl-2 expression in squamous cell carcinoma of the head and neck" . Cancer 1999 ; 85 : 164-70 .

206 . Pezzella F, Tse AG, Cordell JL, Pulford KA, Gatter KC, Mason DY . "Expression of the bcl-2 oncogene protein is not specific for the 14;18 chromosomal translocation" . Am J Pathol 1990 ; 137 : 225-32 .

207 . Pezzella F, Turley H, Kuzu I, Tungekar MF, Dunnill MS, Pierce CB, Harris A, Gatter KC, Mason DY . "Bcl-2 protein in non-small lung carcinoma" . N Engl J Med 1993 ; 329 : 690-4 .


116

208 . Piffko J, Bankfalvi A, Öfner D, Joos U, Böcker W, Schmid KW . "lmmunohistochemical detection of p53 protein in archival tissues from squamous cell carcinomas of the oral cavity using wet autoclave antigen retrieval" . J Pathol 1995 ; 176 : 69-75 .

209 . Pilotti S, Collini P, Del Bo R, Cattoretti G, Pierotti MA, Rilke F . "A novel panel of antibodies that segregates immunocytochemically poorly differentiated carcinoma from undifferentiated carcinoma of the thyroid gland" . Am J Surg Pathol 1994 ; 18 : 1054-64 .

210 . Pindborg JJ, Reichart PA, Smith CJ, van der Waal I . Histological typing of cancer and precancer of the oral mucosa , 2nd edition. Berlin : Springer , 1997 .

211 . Pruneri G, Pignataro L, Carboni N, Luminari S, Capaccio P, Neri A, Buffa R . "MDM-2 oncoprotein overexpression in laryngeal squamous cell carcinoma: association with wild-type p53 accumulation" . Mod Pathol 1997 ; 10 : 785-92 .

212 . Quelle DE, Cheng M, Ashmun RA, Sherr CJ . "Cancer-associated mutations at the INK4a locus cancel cell cycle arrest by p16(INK4a) but not by the alternative reading frame protein p19(ARF)" . Proc Natl Acad Sci U S A 1997 ; 94 : 669-73 .

213 . Quelle DE, Zindy F, Ashmun RA, Sherr CJ . "Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest" . Cell 1995 ; 83 : 993-1000 .

214 . Raycroft L, Wu H, Lozano G . "Transcriptional activation by wild-type but not transforming mutants of the p53 anti-oncogene" . Science 1990 ; 249 : 1049-51 .

215 . Reed JC . "Bcl-2 and the regulation of programmed cell death" . J Cell Biol 1994 ; 124 : 1-6 .

216 . Reisman D, Greenberg M, Rotter V . "Human p53 oncogene contains one promoter upstream of exon 1 and a second, stronger promoter within exon 1" . Proc Natl Acad Sci U S A 1988 ; 85 : 5146-50 .

217 . Robert Koch-Institut . Geschätzte Zahl jährlich neu an Krebs Erkrankter, Deutschland 1997 . http://www.rki.de/GBE/KREBS/KREBS.HTM , 1999 .

218 . Rosenberg CL, Kim HG, Shows TB, Kronenberg HM, Arnold A . "Rearrangement and overexpression of D11S287E, a candidate oncogene on chromosome 11q13 in benign parathyroid tumors" . Oncogene 1991 ; 6 : 449-53 .

219 . Roy PH, Bears SO . "Spinal accessory nerve in radical neck dissections" . Am J Surg 1969 ; 118 : 800-4 .

220 . Rubinfeld B, Souza B, Albert B, Müller I, Chamberlain O, Masiarz SC . "Association of the APC gene product with beta-catenin" . Science 1993 ; 262 : 1731-4 .

221 . Salmi M, Grön-Virta K, Sointu P, Grenman R, Kalimo H, Jalkanen S . "Regulated expression of exon v6 containing isoforms of CD44 in man: downregulation during malignant transformation of tumours of squamocellular origin" . J Cell Biol 1993 ; 122 : 431-42 .

222 . Sarnow P, Ho YS, Williams J, Levine AJ . "Adenovirus E1b-58kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54 kd cellular protein in transformed cells" . Cell 1982 ; 28 : 387-94 .

223 . Sauter ER, Cleveland D, Trock B, Ridge JA, Klein-Szanto AJ . "P53 is overexpressed in fifty percent of pre-invasive lesions of head and neck epithelium" . Carcinogenesis 1994 ; 15 : 2269-74 .

224 . Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM . "The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53" . Cell 1990 ; 63 : 1129-36 .

225 . Schmitz-Moormann P, Gebert G, Thomas C . Allgemeine Pathologie . Stuttgart : Schattauer , 1995 , 161-209 .


117

226 . Screaton GR, Bell MV, Bell JI, Jackson DG . "The identification of a new alternative exon with highly restricted tissue expression in transcripts encoding the mouse Pgp-1 (CD44) homing receptor. Comparison of all 10 variable exons between mouse, human, and rat" . J Biol Chem 1993 ; 268 : 12235-8 .

227 . Screaton GR, Bell MV, Jackson DG, Cornelis FB, Gerth U, Bell JI . "Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons" . Proc Natl Acad Sci U S A 1992 ; 89 : 12160-4 .

228 . Seiter S, Arch R, Reber S, Komitowski D, Hofmann M, Ponta H, Herrlich P, Matzkus S, Zöller M . "Prevention of tumor metastasis formation by anti-variant CD44" . J Exp Med 1993 ; 177 : 443-55 .

229 . Seiter S, Tilgen W, Herrmann K, Schadendorf D, Patzelt E, Möller P, Zöller M . "Expression of CD44 splice variants in human skin and epidermal tumours" . Virchows Arch 1996 ; 428 : 141-9 .

230 . Selivanova G, Wiman KG . "P53: a cell cycle regulator activated by DNA damage" . Adv Cancer Res 1995 ; 66 : 143-80 .

231 . Serrano M, Hannon GJ, Beach D . "A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4" . Nature 1993 ; 366 : 704-7 .

232 . Shapiro SS, Wilk MB, Chen HJ . "A comparative study of various tests of normality" . J Am Statist Assoc 1968 ; 63 : 1343-72 .

233 . Shaulsky G, Goldfinger N, Ben-Zeev A, Rotter V . "Nuclear accumulation of p53 protein is mediated by several nuclear localization signals and plays a role in tumorigenesis" . Mol Cell Biol 1990 ; 10 : 6565-77 .

234 . Sherr CJ . "G1 phase progression: cycling on cue" . Cell 1994 ; 79 : 551-5 .

235 . Sherrington PD, Forster A, Seawright A, van Heyningen V, Rabbitts TH . "Human RAG2, like RAG1, is on chromosome 11 band p13 and therefore not linked to ataxia teleangiectasia complementation groups" . Genes Chromosom Cancer 1992 ; 5 : 404-6 .

236 . Shieh SY, Ikeda M, Taya Y, Prives C . "DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2" . Cell 1997 ; 91 : 325-34 .

237 . Shimazui T, Giroldi LA, Bringuier PP, Oosterwijk E, Schalken JA . "Complex cadherin expression in renal cell carcinoma" . Cancer Res 1996 ; 56 : 3234-7 .

238 . Shimizu S, Narita M, Tsujimoto Y . "Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC" . Nature 1999 ; 399 : 483-7 .

239 . Shin DM, Kim J, Ro JY, Hittelman J, Roth JA, Hong WK, Hittelman WN . "Activation of p53 gene expression in premalignant lesions during head and neck tumorigenesis" . Cancer Res 1994 ; 54 : 321-6 .

240 . Shintani S, Yoshihama Y, Emilio AR, Matsumura T . "Overexpression of p53 is an early event in the tumorigenesis of oral squamous call carcinomas" . Anticancer Res 1995 ; 15 : 305-8 .

241 . Shiozaki H, Kadowaki T, Doki Y, Inoue M, Tamura S, Oka H, Iwazawa T, Matsui S, Shimaya K, Takeichi M . "Effect of epidermal growth factor on cadherin-mediated adhesion in a human oesophageal cancer cell line" . Br J Cancer 1995 ; 71 : 250-8 .

242 . Shiozaki H, Oka H, Inoue M, Tamura S, Monden M . "E-cadherin mediated adhesion system in cancer cells" . Cancer 1996 ; 77 : 1605-13 .

243 . Singh BB, Chandler FW, Whitaker SB, Forbes-Nelson AE . "Immunhistochemical evaluation of bcl-2 oncoprotein in oral dysplasia and carcinoma" . Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998 ; 85 : 692-8 .

244 . Sliutz G, Tempfer C, Winkler S, Kohlberger P, Reinthaller A, Kainz C . "Immunohistochemical and serological evaluation of CD44 splice variants in human ovarian cancer" . Br J Cancer 1995 ; 72 : 1494-7 .


118

245 . Sobin LH, Wittekind C , eds. TNM classification of malignant tumours , 5th edition. New York : Wiley-Liss , 1997 , 17-32 .

246 . Soukka T, Salmi M, Joensuu H, Hakkinen L, Sointu P, Koulu L, Kalimo K, Klemi P, Grenman R, Jalkanen S . "Regulation of CD44v6-containing isoforms during proliferation of normal and malignant epithelial cells" . Cancer Res 1997 ; 57 : 2281-9 .

247 . Spafford MF, Koeppe J, Pan Z, Archer PG, Meyers AD, Franklin WA . "Correlation of tumor markers p53, bcl-2, CD34, CD44H, CD44v6, and Ki-67 with survival and metastasis in laryngeal squamous cell carcinoma" . Arch Otolaryngol Head Neck Surg 1996 ; 122 : 627-32 .

248 . Stamenkovic I, Aruffo A, Amiot M, Seed B . "The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate-bearing cells" . EMBO J 1991 ; 10 : 343-8 .

249 . Statistisches Bundesamt . Statistisches Jahrbuch 1999 für die Bundesrepublik Deutschland . Stuttgart : Metzler-Poeschel , 1999 , 424-7 .

250 . Stauder R, Eisterer W, Thaler J, Günthert U . "CD44 variant isoforms in non-Hodgkin's lymphoma: a new independent prognostic factor" . Blood 1995 ; 85 : 2885-99 .

251 . Stenger JE, Mayr GA, Mann K, Tegtmeyer P . "Formation of stable p53 homotetramers and multiples of tetramers" . Mol Carcinog 1992 ; 5 : 102-6 .

252 . Stewart BW . "Mechanisms of apoptosis: integration of genetic, biochemical, and cellular indicators" . J Natl Cancer Inst 1994 ; 86 : 1286-96 .

253 . Stoll C, Baretton G, Ahrens C, Löhrs U . "Prognostic significance of apoptosis and associated factors in oral squamous cell carcinoma" . Virchows Arch 2000 ; 436 : 102-8 .

254 . Stoll C, Baretton G, Löhrs U . "The influence of p53 and associated factors on the outcome of patients with oral squamous cell carcinoma" . Virchows Arch 1998 ; 433 : 427-33 .

255 . Stoll C, Baretton G, Soost F, Domide P, Terpe HJ, Löhrs U . "Prognostic importance of the expression of CD44 splice variants in oral squamous cell carcinomas" . Oral Oncol 1999 ; 35 : 484-9 .

256 . Stott FJ, Bates S, James MC, McConnell BB, Starborg M, Brookes S, Palmero I, Ryan K, Hara E, Voudsen KH, Peters G . "The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2" . EMBO J 1998 ; 17 : 5001-14 .

257 . Strachan DS . "Histology of the oral mucosa and tonsils" . In: Avery JK, Steele PF, eds. Oral development and histology , 2. ed. New York : Thieme , 1994 : 298-320 .

258 . Streit M, Schmidt R, Hilgenfeld RU, Thiel E, Kreuser ED . "Adhesion receptors in malignant transformation and dissemination of gastrointestinal tumors" . J Mol Med 1996 ; 74 : 253-68 .

259 . Su LK, Vogelstein B, Kinzler KW . "Association of the APC tumor suppressor protein with catenins" . Science 1993 ; 262 : 1734-7 .

260 . Taher TE, Smit L, Griffioen AW, Schilder-Tol EJ, Borst J, Pals ST . "Signaling through CD44 is mediated by tyrosine kinases. Association with p56lck in T lymphocytes" . J Biol Chem 1996 ; 271 : 2863-7 .

261 . Takayama T, Shiozaki H, Inoue M, Tamura S, Oka H, Kadowaki T, Takatsuka Y, Nagafuchi A, Tsukita S, Mori T . "Expression of E-cadherin and alpha-catenin molecules in human breast cancer tissue and association with clinicopathological features" . Int J Oncol 1994 ; 5 : 775-80 .

262 . Takayama T, Shiozaki H, Shibamoto S, Oka H, Kimura Y, Tamura S, Inoue M, Monden T, Ito F, Monden M . "Beta-catenin expression in human cancers" . Am J Pathol 1996 ; 148 : 39-46 .


119

263 . Takeichi M . "Functional correlation between cell adhesion properties and some cell surface proteins" . J Cell Biol 1977 ; 75 : 464-74 .

264 . Takeichi M . "Cadherin cell adhesion receptors as a morphogenetic regulator" . Science 1991 ; 251 : 1451-5 .

265 . Takeichi M . "Cadherins in cancer: implications for invasion and metastasis" . Curr Opin Cell Biol 1993 ; 5 : 806-11 .

266 . Tempfer C, Gitsch G, Haeusler G, Reinthaller A, Koelbl H, Kainz C . "Prognostic value of immunohistochemically detected CD44 expression in patients with carcinoma of the vulva" . Cancer 1996 ; 78 : 273-7 .

267 . Terpe HJ, Christiansen H, Gonzalez M, Berthold F, Lampert F . "Differentiation and prognosis of neuroblastoma in correlation to the expression of CD44s" . Eur J Cancer 1995 ; 31A : 549-52 .

268 . Terpe HJ, Stark H, Prehm P, Günthert U . "CD44 variant isoforms are preferentially expressed in basal epithelial of non-malignant human fetal and adult tissues" . Histochemistry 1994 ; 101 : 79-89 .

269 . Terpe HJ, Storkel S, Zimmer U, Anquez V, Fischer C, Pantel K, Günthert U . "Expression of CD44 isoforms in renal cell tumors. Positive correlation to tumor differentiation" . Am J Pathol 1996 ; 148 : 453-63 .

270 . Thornberry NA, Lazebnik Y . "Caspases: enemies within" . Science 1998 ; 281 : 1312-6 .

271 . Toyama-Sorimachi N, Miyasaka M . "A novel ligand for CD44 is sulfated proteoglycan" . Int Immunol 1994 ; 6 : 655-60 .

272 . Trent JM, Wiltshire R, Su LK, Nicolaides NC, Vogelstein B, Kinzler KW . "The gene for the APC-binding protein beta-catenin (CTNNB1) maps to chromosome 3p22, a region frequently altered in human malignancies" . Cytogenet Cell Genet 1995 ; 71 : 343-4 .

273 . Trochon V, Mabilat C, Bertrand P, Legrand Y, Smadja-Joffe F, Soria C, Delpech B, Lu H . "Evidence of involvement of CD44 in endothelial cell proliferation, migration and angiogenesis in vitro" . Int J Cancer 1996 ; 66 : 664-8 .

274 . Tsujimoto Y, Croce CM . "Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma" . Proc Natl Acad Sci U S A 1986 ; 83 : 5214-8 .

275 . Tsujimoto Y, Ikegaki N, Croce CM . "Characterization of the protein product of bcl-2, the gene involved in human follicular lymphoma" . Oncogene 1987 ; 2 : 3-7 .

276 . Tsukita S, Oishi K, Sato N, Kamai A . "ERM family members as molecular linkers between the cell surface glycoprotein CD44 and actin-based cytoskeletons" . J Cell Biol 1994 ; 126 : 391-401 .

277 . Tsukita SH, Tsukita S, Nagafuchi A, Yonemura S . "Molecular linkage between cadherins and actin filaments in cell-cell adherens junctions" . Curr Opin Cell Biol 1992 ; 4 : 834-9 .

278 . Underhill C . "CD44: the hyaluronan receptor" . J Cell Science 1992 ; 103 : 293-8 .

279 . Underhill C, Nguyen HA, Shizari M, Culty M . "CD44 positive macrophages take up hyaluronan during lung development" . Dev Biol 1993 ; 155 : 324-36 .

280 . Vermeulen SJ, Bruyneel EA, van Roy FM, Mareel MM, Bracke ME . "Activation of the E-cadherin/catenin complex in human MCF-7 breast cancer cells by all-trans-retinoic acid" . Br J Cancer 1995 ; 72 : 1447-53 .

281 . Vogelstein B, Kinzler KW . "P53 function and dysfunction" . Cell 1992 ; 70 : 523-6 .

282 . Vojtêsek B, Bártek J, Midgley CA, Lane DP . "An immunochemical analysis of the human nuclear phosphoprotein p53. New monoclonal antibodies and epitope mapping using recombinant p53" . J Immunol Meth 1992 ; 151 : 237-44 .


120

283 . Wagner G , Hrsg. Tumorlokalisationsschlüssel , 5. Auflage. Berlin : Springer , 1993 , 14-23 .

284 . Wang JY . "Retinoblastoma protein in growth suppression and death protection" . Curr Opin Genet Dev 1997 ; 7 : 39-45 .

285 . Warnakulasuriya KA, Johnson NW . "Expression of p53 mutant nuclear phosphoprotein in oral carcinoma and potentially malignant oral lesions" . J Oral Pathol Med 1992 ; 21 : 404-8 .

286 . Washington K, Gottfried MR, Telen MJ . "Expression of the cell adhesion molecule CD44 in gastric adenocarcinomas" . Hum Pathol 1994 ; 25 : 1043-9 .

287 . Weinberg RA . "The retinoblastoma protein and cell cycle control" . Cell 1995 ; 81 : 323-30 .

288 . Werness BA, Levine AJ, Howley PM . "Association of human papillomavirus types 16 and 18 E6 proteins with p53" . Science 1990 ; 248 : 76-9 .

289 . Whalen GF, Sharif SF . "Locally increased metastatic efficiency as a reason for preferential metastasis of solid tumors to lymph nodes" . Ann Surg 1992 ; 215 : 166-71 .

290 . Whyte P, Buchkovich KJ, Horowitz JM, Friend SH, Raybuck M, Weinberg RA, Harlow E . "Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product" . Nature 1988 ; 334 : 124-9 .

291 . Wight AJ, Ogden GR . "Possible mechanisms by which alcohol may influence the development of oral cancer - a review" . Oral Oncol 1998 ; 34 : 441-7 .

292 . Willis RA . The spread of tumors in the human body . London : Butterworth , 1952 .

293 . Wilson GD, Richman PI, Dische S, Saunders MI, Robinson B, Daley FM, Ross DA . "P53 status of head and neck cancer: relation to biological characteristics and outcome of radiotherapy" . Br J Cancer 1995 ; 71 : 1248-52 .

294 . Windle JJ, Albert DM, O‘Brien JM, Marcus DM, Disteche CM, Bernards R, Mellon PL . "Retinoblastoma in transgenic mice" . Nature 1990 ; 343 : 665-9 .

295 . Wood MW, Medina JE, Thompson GC, Houck JR, Min KW . "Accumulation of the p53 tumor-suppressor gene product in oral leukoplacia" . Otolaryngol Head Neck Surg 1994 ; 111 : 758-63 .

296 . World Health Organization, Percy C, van Holten V, Muir C , eds. International classification of diseases for oncology , 2nd edition. Geneva : World Health Organization , 1990 .

297 . Wu X, Bayle JH, Olson D, Levine AJ . "The p53-mdm2 autoregulatory feedback loop" . Genes Dev 1993 ; 7 : 1126-32 .

298 . Wynford-Thomas D . "P53 in tumour pathology: can we trust immunocytochemistry?" J Pathol 1992 ; 166 : 329-30 .

299 . Xiao ZX, Chen J, Levine AJ, Modjtahedi N, Xing J, Sellers WR, Livingston DM . "Interaction between the retinoplastoma protein and the oncoprotein MDM2" . Nature 1995 ; 375 : 694-8 .

300 . Xie X, De Angelis P, Clausen OP, Boysen M . "Prognostic significance of proliferative and apoptotic markers in oral tongue squamous cell carcinomas" . Oral Oncol 1999 ; 35 : 502-9 .

301 . Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D . "P21 is a universal inhibitor of cyclin kinases" . Nature 1993 ; 366 : 701-4 .

302 . Yamaguchi A, Urano T, Goi T, Saito M, Takeuchi K, Hirose K, Nakagawara G, Shiku H, Furukana K . "Expression of a CD44 variant containing exons 8 to 10 is a useful independent factor for the prediction of prognosis in colorectal cancer patients" . J Clin Oncol 1996 ; 14 : 1122-7 .


121

303 . Yandell DW, Campbell TA, Dayton SH, Petersen R, Walton D, Little JB, McConkie-Rosell A, Buckley E, Dryja T . "Oncogenic point mutations in the human retinoblastoma gene: their application to genetic counseling" . New Engl J Med 1989 ; 321 : 1689-95 .

304 . Yang B, Yang BL, Savani RC, Turley EA . "Identification of a common hyaluronan binding motif in the hyaluronan binding proteins RHAMM, CD44 and link protein" . EMBO J 1994 ; 13 : 286-96 .

305 . Zetter BR . "Adhesion molecules in tumor metastasis" . Semin Cancer Biol 1993 ; 4 : 219-29 .

306 . Zhang H, Xiong Y, Beach D . "Proliferating cell nuclear antigen and p21 are components of multiple cell cycle kinase complexes" . Mol Biol Cell 1993 ; 4 : 897-906 .

307 . Zhang HS, Postigo AA, Dean DC . "Active transcriptional repression by the Rb-E2F complex mediates G1 arrest triggered by p16(INK4a), TGF-beta, and contact inhibition" . Cell 1999 ; 97 : 53-61 .

308 . Zhang Y, Xiong Y, Yarbrough WG . "ARF promotes MDM2 degregation and stabilizes p53: ARF-INK4a locus deletion impairs both Rb and p53 tumor suppressor pathways" . Cell 1998 ; 92 : 725-34 .

309 . Zhu D, Bourguignon L . "Overexpression of CD44 in p185(neu)-transfected NIH3T3 cells promotes an up-regulation of hyaluronic acid-mediated membrane-cytoskeleton interaction and cell adhesion" . Oncogene 1996 ; 12 : 2309-14 .

310 . Zöller M . "CD44: physiological expression of distinct isoforms as evidence for organ-specific metastasis formation" . J Mol Med 1995 ; 73 : 425-38 .


© Die inhaltliche Zusammenstellung und Aufmachung dieser Publikation sowie die elektronische Verarbeitung sind urheberrechtlich geschützt. Jede Verwertung, die nicht ausdrücklich vom Urheberrechtsgesetz zugelassen ist, bedarf der vorherigen Zustimmung. Das gilt insbesondere für die Vervielfältigung, die Bearbeitung und Einspeicherung und Verarbeitung in elektronische Systeme.

DiML DTD Version 2.0
Zertifizierter Dokumentenserver
der Humboldt-Universität zu Berlin
HTML - Version erstellt am:
Tue Apr 3 17:33:46 2001